Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Unlocking Durable Allogeneic Cell Therapy 5/13/2026

    Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

  2. Supporting Global Approval Of A First-In-Class Gene Therapy For A Rare Genetic Disorder 5/27/2026

    Global approvals for a first-in-class gene therapy don’t happen by chance. See how adaptive oversight and inspection readiness kept a complex rare disease program moving forward.

  3. 12-Day Stability Of PRIME-XV T Cell Expansion Supplemented With CTGrade GMP Cytokines 10/17/2025

    Discover how T-cell culture media supplemented with key cytokines can maintain full functionality and support robust expansion for up to 12 days at room temperature.

  4. Best Practices For Oncolytic Virus Design, Development, Manufacturing 3/12/2025

    Oncolytic viruses have the potential to revolutionize standard cancer treatment, but their continued progress hinges on meeting a number of goals linked to safety, efficacy, and commercial scale-up.

  5. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

  6. Rescuing A Global Program For NDA Success 8/12/2025

    Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.

  7. Bridging Studies For Producer Cell Line Adoption: Regulatory And Development Perspectives 6/1/2026

    Explore how analytical comparability, risk assessment, and bridging strategies can support a smooth and compliant platform transition.

  8. Manufacturing Readiness: Why Compliance Is Won Or Lost On The Floor 8/6/2026

    Achieve continuous regulatory readiness by embedding ALCOA++ compliance directly into manufacturing workflows to eliminate paper-based documentation risks.

  9. Achieving Titer Increase Up To 4-Fold While Maintaining Product Quality 8/29/2024

    Discover customizable solutions for antibody manufacturing, as well as services for media optimization, feeding strategy optimization, and format conversion.

  10. Using Plant Peptones To Boost Plasmid Yield And Induction 2/12/2026

    Uncover how Nu‑Tek’s plant-based peptones support E. coli growth, plasmid yield, and controlled induction, offering a sustainable, animal-free alternative for biopharmaceutical cell culture.